GENEAXS
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

GENEAXS Trademark

Serial Number: 90044779 • Registration: 6828356

GENEAXS is a trademark filed by EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC. on July 9, 2020. The trademark is classified under Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC. (287 trademarks)

ONE EXPRESS WAY
ST. LOUIS, MO 63121

Entity Type: 03

Trademark Details

Filing Date

July 9, 2020

Registration Date

August 23, 2022

Published for Opposition

March 16, 2021

Goods & Services

Providing patient educational services, namely, conducting programs in the field of chronic diseases and specialty medications, and distributing course materials in connection therewith; providing patient educational services, namely, conducting programs in the field of proper product-reconstitution and administration; providing patient educational services, namely, providing resources appropriate for support of disease management, namely, providing a website featuring non-downloadable publications in the nature of brochures and newsletters related to the support of disease management; providing a website featuring non-downloadable videos related to the support of disease management; educational services for product manufacturers, pharmaceutical clinicians and biotech companies, clinicians, contract research organizations and insurance providers, namely, conducting classes, one-on-one sessions and telephonic workshops in the field of clinical research and distributing course materials in connection therewith

Retail specialized pharmacy services focusing on specific diseases, conditions and therapies, namely, specialized retail pharmacy services serving groups of patients with common medical conditions and medication needs

Medical services, namely, health and medication support services for groups of patients with common medical conditions and medication needs

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 23, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 23, 2022 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 16, 2022 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 15, 2022 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 17, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 17, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 17, 2022 TROA
SOU TEAS EXTENSION RECEIVED
May 11, 2022 EEXT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 17, 2021 GNRN
NON-FINAL ACTION E-MAILED
Dec 17, 2021 GNRT
SU - NON-FINAL ACTION - WRITTEN
Dec 17, 2021 CNRT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 20, 2021 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Nov 19, 2021 SUPC
SOU EXTENSION 1 GRANTED
Nov 19, 2021 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 19, 2021 AITU
USE AMENDMENT FILED
Nov 11, 2021 IUAF
SOU EXTENSION 1 FILED
Nov 11, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 11, 2021 EEXT
TEAS STATEMENT OF USE RECEIVED
Nov 11, 2021 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 11, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 16, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 16, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 24, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 8, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 3, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 3, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 3, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 14, 2020 GNRN
NON-FINAL ACTION E-MAILED
Sep 14, 2020 GNRT
NON-FINAL ACTION WRITTEN
Sep 14, 2020 CNRT
ASSIGNED TO EXAMINER
Sep 4, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 5, 2020 NWOS
NEW APPLICATION ENTERED
Jul 13, 2020 NWAP